Protagenic Therapeutics, Inc.\new Accounts Payable and Other Accrued Liabilities
Protagenic Therapeutics, Inc.\new (PTIX) had Accounts Payable and Other Accrued Liabilities of $1.08 million as of 2025-03-31, per its 10-Q filed 2025-05-13.
Financial Statements › Balance Sheet › Liabilities
us-gaap:AccountsPayableAndOtherAccruedLiabilities · last filed 2025-05-13
- 2025-03-31: Accounts Payable and Other Accrued Liabilities $1.08M.
- 2024-12-31: Accounts Payable and Other Accrued Liabilities $942.76K.
- 2024-09-30: Accounts Payable and Other Accrued Liabilities $789.32K.
- 2024-06-30: Accounts Payable and Other Accrued Liabilities $674.56K.
| Period end | Accounts Payable and Other Accrued Liabilities |
|---|---|
| 2025-03-31 | $1.08M 10-Q · filed 2025-05-13 |
| 2024-12-31 | $942.76K 10-Q · filed 2025-05-13 |
| 2024-09-30 | $789.32K 10-Q · filed 2024-11-14 |
| 2024-06-30 | $674.56K 10-Q · filed 2024-08-14 |
| 2024-03-31 | $446.10K 10-Q · filed 2024-05-15 |
| 2023-12-31 | $655.25K 10-K · filed 2025-03-31 |
| 2023-09-30 | $860.34K 10-Q · filed 2023-11-14 |
| 2023-06-30 | $1.11M 10-Q · filed 2023-08-14 |
| 2022-12-31 | $775.63K 10-K/A · filed 2024-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Aditxt, Inc. (ADTX) | United States | $0.000B | |
| Rafael Holdings, Inc. (RFL) | United States | $0.000B | -0.00 |